Kurapeev Dmitry I, Kabanov Viktor O, Grebennik Vadim K, Sheshurina Tatyana A, Dorofeykov Vladimir V, Galagudza Michael M, Shlyakhto Eugene V
Institute of Experimental Medicine, Federal Almazov Medical Research Centre, Saint Petersburg, Russian Federation.
Institute of Heart and Vessels, Federal Almazov Medical Research Centre, Saint Petersburg, Russian Federation.
J Cardiothorac Surg. 2015 Jan 22;10:9. doi: 10.1186/s13019-015-0206-0.
Several studies have demonstrated that local ischemic preconditioning can reduce myocardial ischemia-reperfusion injury in cardiac surgery patients; however, preconditioning has not become a standard cardioprotective intervention, primarily because of the increased risk of atheroembolism during repetitive aortic cross-clamping. In the present study, we aimed to describe and validate a novel technique of preconditioning induction.
Patients undergoing coronary artery bypass grafting (12 women and 78 men; mean age, 56 ± 11 years) were randomized into 3 groups: (1) Controls (n = 30), (2) Perfusion (n = 30), and (3) Preconditioning (n = 30). All patients were operated under cardiopulmonary bypass using normothermic blood cardioplegia. Preconditioning was induced by subjecting the hemodynamically unloaded heart to 2 cycles of 3 min of ischemia and 3 min of reperfusion with normokalemic blood prior to cardioplegia. In the Perfusion group, the heart perfusion remained unaffected for 12 min. Troponin I (TnI) levels were analyzed before surgery, and 12, 24, 48 h, and 7 days after surgery. The secondary endpoints included the cardiac index, plasma natriuretic peptide level, and postoperative use of inotropes.
Preconditioning resulted in a significant reduction in the TnI level on the 7th postoperative day only (0.10 ± 0.05 and 0.33 ± 0.88 ng/ml in Preconditioning and Perfusion groups, respectively, P < 0.05). In addition, cardiac index was significantly higher in the Preconditioning group than in the Control and Perfusion groups just after weaning from cardiopulmonary bypass. The number of patients requiring inotropic support with ≥ 2 agents after surgery was significantly lower in the Preconditioning and Perfusion group than in the Control group (P < 0.05). No complications of the procedure were recorded in the Preconditioning group.
The preconditioning procedure described can be performed safely in cardiac surgery patients. The application of this technique of preconditioning was associated with certain benefits, including improved left ventricular function after weaning from cardiopulmonary bypass and a reduced need for inotropic support. However, the infarct-limiting effect of preconditioning in the early postoperative period was not evident. The procedure does not involve repetitive aortic cross-clamping, thus avoiding possible embolic complications.
多项研究表明,局部缺血预处理可减轻心脏手术患者的心肌缺血再灌注损伤;然而,预处理尚未成为标准的心脏保护干预措施,主要是因为重复主动脉阻断期间动脉粥样硬化栓塞风险增加。在本研究中,我们旨在描述和验证一种新的预处理诱导技术。
接受冠状动脉搭桥术的患者(12名女性和78名男性;平均年龄56±11岁)被随机分为3组:(1)对照组(n = 30),(2)灌注组(n = 30),(3)预处理组(n = 30)。所有患者均在体外循环下使用常温血液停搏液进行手术。预处理是通过在心脏停搏前使血流动力学卸载的心脏经历2个周期的3分钟缺血和3分钟复灌注(使用正常血钾血液)来诱导的。在灌注组中,心脏灌注在12分钟内保持不受影响。在手术前以及手术后12、24、48小时和7天分析肌钙蛋白I(TnI)水平。次要终点包括心脏指数、血浆利钠肽水平和术后使用的血管活性药物。
预处理仅在术后第7天导致TnI水平显著降低(预处理组和灌注组分别为0.10±0.05和0.33±0.88 ng/ml,P<0.05)。此外,在体外循环脱机后,预处理组的心脏指数显著高于对照组和灌注组。预处理组和灌注组术后需要使用≥2种血管活性药物支持的患者数量显著低于对照组(P<0.05)。预处理组未记录到该手术的并发症。
所描述的预处理程序可在心脏手术患者中安全进行。这种预处理技术的应用具有一定益处,包括体外循环脱机后左心室功能改善以及血管活性药物支持需求减少。然而,预处理在术后早期的梗死限制作用并不明显。该程序不涉及重复主动脉阻断,从而避免了可能的栓塞并发症。